ERBB2 and breast carcinoma: For clinical purposes and treatment decisions, breast cancer is biologically classified according to the presence or absence of expression of the hormone receptors (HRs) for estrogen and progesterone and a possible amplification of the human epidermal growth factor receptor 2 (HER2).